Ranked #8,496 of 8,699 institutional investors
Monashee Investment Management LLC
Boston, MA
$32.5M
US stock portfolio at live prices · today +$189K (+0.59%)
Live prices, last trade 12:01 PM ET
- Value at quarter end (Q3 2026)
- $33.4M
- Change from Q2 2026
- −$20.7M (−38.31%)
- Positions
- 13 · 10 new, 12 sold out
- Filed
- Nov 6, 2026
Not counted in the ranking: none$9.6M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesADT 15.2%SYY 13.5%IMMX 9.98%SLDB 7.99%ENB 7.14%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ADT ADT Inc. | 500,000 | $4.9M | 15.2% | Reduced −17% |
| SYY Sysco Corporation | 55,000 | $4.4M | 13.5% | New |
| IMMX Immix Biopharma, Inc. | 450,000 | $3.2M | 9.98% | New |
| SLDB Solid Biosciences Inc. | 410,000 | $2.6M | 7.99% | Reduced −18% |
| ENB Enbridge Inc. | 50,000 | $2.3M | 7.14% | New |
| BLSM BlossomHill Therapeutics, Inc. | 80,000 | $1.2M | 3.60% | New |
| ETRA Electra Therapeutics, Inc. | 100,000 | $855K | 2.63% | New |
| IMA ImageneBio, Inc. | 177,094 | $681K | 2.10% | Reduced −8% |
| HGTY Hagerty, Inc. | 35,000 | $574K | 1.77% | New |
| OIG Orion180 Insurance Group Inc. | 55,000 | $570K | 1.76% | New |
| AVAH Aveanna Healthcare Holdings Inc. | 50,000 | $548K | 1.69% | New |
| YARW Yarrow Bioscience, Inc. | 40,000 | $531K | 1.64% | New |
| PYXS Pyxis Oncology, Inc. | 229,310 | $430K | 1.32% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| SYRE Spyre Therapeutics, Inc. | 50,000 | $4.7M |
| DLR Digital Realty Trust, Inc. | 25,000 | $4.2M |
| TNGX Tango Therapeutics, Inc. | 100,000 | $2.2M |
| AKR Acadia Realty Trust | 85,385 | $1.7M |
| GOOGL Alphabet Inc. | 6,000 | $1.7M |
| GOOG Alphabet Inc. | 6,000 | $1.6M |
| LEGN Legend Biotech Corporation | 85,385 | $1.3M |
| WHK WhiteHawk Minerals Corp. | 51,232 | $1.2M |
| PTRN Pattern Group Inc. | 64,039 | $1.2M |
| MLTX MoonLake Immunotherapeutics | 75,000 | $829K |
| TSHA Taysha Gene Therapies, Inc. | 200,000 | $750K |
| KARD Kardigan, Inc. | 42,693 | $519K |